Dalman AQ Adverse Reactions

Oral or nasal inhalation: Frequency depends upon population studied and dosing used. Reactions reported are representative of multiple oral formulations (> 3 %).
Central Nervous System: Headache (2% to 22%), fever (1% to 7%).
Gastrointestinal: Nausea / vomiting (1% to 8%).
Neuromuscular & skeletal: Muscle injury (1% to 5%), musculoskeletal pain (1% to 5%), back problems (<1% to 4%).
Respiratory: Upper respiratory tract infection (14% to 22%), throat irritation (3% to 22%), nasal congestion (4% to 16%), pharyngitis (6% to 14%), oral candidiasis (<1% to 11%), sinusitis / sinus infection (3% to 10%), rhinitis (1% to 9%), dysphonia (<1% to 8%).
Miscellaneous: Viral infection (2% to 5%).
< 3 % (Limited to important or life threatening): Aggression, agitation, cataracts, cholecystitis, Churg Strauss syndrome, Cushingoid features, depression, dyspnea, eosinophilic conditions, fungal skin infection, gastroenteritis, glaucoma, goiter, growth velocity reduction (in children / adolescents), increased intraocular pressure, lower respiratory infections, migraine, mood disorders, nasopharyngitis, nervousness, nose/throat polyps, oral ulcerations, paradoxical bronchospasm, paralysis of cranial nerves, photodermatitis, pruritus, skin rash, throat constriction, urticaria, vasculitis.
Contact the physician immediately in case of an unexpected effect.